1-Methyl-2-methylidene-2,3-dihydro-1H-indole | 115560-35-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-Methyl-2-methylidene-2,3-dihydro-1H-indole
• 英文别名: 1-methyl-2-methylidene-3H-indole
• CAS: 115560-35-5
• 化学式: C₁₀H₁₁N
• 分子量: 145.2
• InChiKey: IGMUQLGQZWDBBR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] PHOTOPOLYMER COMPRISING A NEW CLASS OF PHOTO INITIATOR<br/>[FR] PHOTOPOLYMÈRE COMPRENANT UNE NOUVELLE CLASSE DE PHOTO-INITIATEUR
  申请人：COVESTRO DEUTSCHLAND AG

  公开号：WO2016096639A1

  公开（公告）日：2016-06-23

  The present invention relates to photopolymer comprising a photopolymerizable component and a photo initiator system. Further aspects of the present invention are a holographic media which comprises such a photopolymer, a display which comprises such a holographic media and the use of such a holographic media to make chip cards, security documents, bank notes and / or holographic optical elements especially for displays.

  本发明涉及包括光聚合物可聚合组分和光引发剂系统的光聚合物。本发明的进一步方面包括包括这种光聚合物的全息介质、包括这种全息介质的显示器以及利用这种全息介质制作芯片卡、安全文件、银行票据和/或用于显示器的全息光学元件。
• DIKETOHYDRAZINE DERIVATIVE COMPOUNDS AND DRUGS CONTAINING THE COMPOUNDS AS THE ACTIVE INGREDIENT
  申请人：Hatayama Akira

  公开号：US20100087442A1

  公开（公告）日：2010-04-08

  The present invention relates to a diketohydrazine derivative of formula (I) and a pharmaceutically acceptable salt thereof (the symbols in the formula have the same meaning as described in the specification). The compound of formula (I) has an inhibitory activity against cysteine protease, and it is useful for the treatment of inflammatory diseases, immune diseases, ischemic diseases, respiratory diseases, circulatory diseases, blood diseases, neuronal diseases, hepatic or biliary diseases, osseous or articular diseases, metabolic diseases, etc. And the compound has inhibitory activity against elastase and it is also useful for the treatment of COPD (chronic obstacle pulmonary diseases).

  本发明涉及式(I)的二酮肼衍生物及其药学上可接受的盐（式中符号与说明书中描述的含义相同）。式(I)化合物具有对半胱氨酸蛋白酶的抑制活性，可用于治疗炎症性疾病、免疫性疾病、缺血性疾病、呼吸系统疾病、循环系统疾病、血液疾病、神经系统疾病、肝胆系统疾病、骨骼或关节疾病、代谢性疾病等。该化合物具有对弹性蛋白酶的抑制活性，也可用于治疗慢性阻塞性肺部疾病（COPD）。
• SYNTHESIS OF CHIRAL 2-(1H-INDAZOL-6-YL)-SPIRO[CYCLOPROPANE-1,3'-INDOLIN]-2'-ONES
  申请人：University Health Network

  公开号：US20150133677A1

  公开（公告）日：2015-05-14

  The present invention is directed to novel synthetic methods for preparing a spiro cyclopropyl indolinone compound represented by Structural Formula (A): or its pharmaceutically acceptable salt thereof. Also included are synthetic intermediates described herein.

  本发明涉及一种新的合成方法，用于制备由结构式(A)所表示的螺环丙基吲哚酮化合物或其药学上可接受的盐。本发明还包括在此处描述的合成中间体。
• KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME
  申请人：Cumming Graham

  公开号：US20130096301A1

  公开（公告）日：2013-04-18

  The present invention is directed to novel synthetic methods for preparing a spiro cyclopropyl indolinone compound represented by Structural Formula (A): (A) or its pharmaceutically acceptable salt thereof. Also included are synthetic intermediates described herein.

  本发明涉及一种新的合成方法，用于制备由结构式（A）表示的螺环丙基吲哚酮化合物或其药学上可接受的盐。本发明还包括本文所述的合成中间体。
• FUNGICIDAL AZOCYCLIC AMIDES
  申请人：E I DU PONT DE NEMOURS AND COMPANY

  公开号：US20140081027A1

  公开（公告）日：2014-03-20

  Disclosed are compounds of Formulae 1, 1A, 1B and 1C including all geometric and stereoisomers, N-oxides, and salts thereof, wherein R 1 , R 2 , R 4a1 , R 4a2 , A, A a , G, M, W, Z 1 , Z 3 , X, J, J 1 and n are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling plant disease caused by a fungal pathogen comprising applying an effective amount of a compound or a composition of the invention.

  本发明公开了公式1、1A、1B和1C的化合物，包括所有的几何和立体异构体、N-氧化物和其盐，其中R1、R2、R4a1、R4a2、A、Aa、G、M、W、Z1、Z3、X、J、J1和n的定义如本文所述。本发明还公开了含有公式1的化合物的组合物，并且公开了一种通过施用本发明中化合物或组合物的有效量来控制由真菌病原体引起的植物病害的方法。